羅曼股份(605289.SH):終止重大資產重組程序
格隆匯3月28日丨羅曼股份(605289.SH)公佈,2023年11月27日,上海羅曼科技股份有限公司召開第四屆董事會第十五次會議,審議通過了《關於籌劃重大資產重組暨關聯交易的議案》,公司擬使用自有或自籌資金向EqualCreationLtd購買目標公司40%股權,並向StuartHetherington、AndrewBrown和JoeJurado購買其各自持有的目標公司15%股權,合計收購目標公司85%股權。公司於2024年3月28日召開了第四屆董事會第十九次會議,審議通過《關於收購PredaptiveODLimited控股權不構成重大資產重組暨終止重大資產重組程序的議案》,經審慎研究,公司決定終止本次重大資產重組程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.